University Hospital Birmingham

How to interpret these research links

Connected source records

The exact organization name University Hospital Birmingham appears in 23 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials23

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

23 shown

Comparison of Cardiac Resynchronisation Therapy (CRT) Response Using High Frequency (HF) - ECG or Q-LV Guided Optimisation for Left Ventricular, Pacing Site.NCT05829876 · lead sponsor · 2023-10-31

UNKNOWN

Relationship Between Acoustic Breath Sounds and SpirometryNCT06039943 · lead sponsor · 2023-03-13

UNKNOWN

Outcome of Overweight AF Patients Following Ablation With a Potential Weight Loss Medication ( GOAL-AF )NCT05221229 · lead sponsor · 2022-04-17

ACTIVE_NOT_RECRUITING

The Influence of Inhaled CorticoSteroids Adherence on Treatment Response to Mepolizumab in Severe Eosinophilic AsthmaNCT05241769 · lead sponsor · 2022-03-01

UNKNOWN

Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKDNCT02502981 · lead sponsor · 2014-06-01

UNKNOWN

Can Enhanced Glycemic Control in Type II Diabetics Improve Myocardial Protection During Coronary Artery Bypass Grafting?NCT00899483 · lead sponsor · 2009-07-01

UNKNOWN

Remission Induction in Very Early Rheumatoid ArthritisNCT00523692 · lead sponsor · 2007-09-01

UNKNOWN

Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in DiabetesNCT00628056 · lead sponsor · 2006-10-01

UNKNOWN

Energetic Abnormalities in Heart Failure With Preserved Ejection FractionNCT00628082 · lead sponsor · 2006-03-01

UNKNOWN

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerNCT00112710 · lead sponsor · 2005-03-01

UNKNOWN

Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone TherapyNCT00554918 · lead sponsor · 2005-02-01

COMPLETED

Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast CancerNCT00003893 · lead sponsor · 1998-07-01

COMPLETED

Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast CancerNCT00003577 · lead sponsor · 1996-03-01

COMPLETED

Tamoxifen in Treating Women With Breast CancerNCT00003678 · lead sponsor · 1991-05-01

UNKNOWN

Experience of Biologic Treatments for Severe Asthma: a SurveyNCT06903780 · collaborator · 2025-01-01

RECRUITING

A Trial to Determine the Efficacy and Safety of Presendin in IIHNCT05347147 · collaborator · 2022-11-18

TERMINATED

Collection of Anonymised Blood Pressure Data During High Risk SurgeryNCT03653624 · collaborator · 2019-10-01

UNKNOWN

Effect of mCPP on Cognitive Control, Appetite, and Neural ResponsesNCT03962829 · collaborator · 2019-02-01

TERMINATED

A Study of RSLV-132 in Subjects With Primary Sjogren's SyndromeNCT03247686 · collaborator · 2017-02-01

COMPLETED

Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During RamadanNCT02694263 · collaborator · 2016-07-01

COMPLETED

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.NCT02641158 · collaborator · 2015-12-01

COMPLETED

Trial for People With Established Type 2 Diabetes During RamadanNCT02292290 · collaborator · 2011-04-01

COMPLETED

Hypothermia to Prevent High Intracranial Pressure in Patients With Acute Liver FailureNCT00670124 · collaborator · 2005-01-01

COMPLETED

Drugs studied in this sponsor's trials

25 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University Hospital Birmingham as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

cyclophosphamide2

epirubicin hydrochloride2

fluorouracil2

methotrexate2

placebo2

canagliflozin1

carboplatin1

chlorthalidone1

Sponsor roles

lead sponsor14

collaborator9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.